Resectable, Borderline Resectable, And Locally Advanced Pancreatic Cancer Biorepository Of Peripheral Blood

Overview

About this study

This biorepository is meant to collect longitudinal peripheral blood research samples for the purposes of biomarker studies. Such studies are meant for the purposes of measuring minimal residual disease in the perioperative setting, assess dynamics of treatment response, and to determine predictive value of risk stratification.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years.
  • Histologically proven pancreatic adenocarcinoma.

Exclusion Criteria:

  • Patients with >1 primary malignancy\.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 5/15/23. Questions regarding updates should be directed to the study team contact.

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ryan Carr, M.D., Ph.D.

Contact us for the latest status

Contact information:

Ryan Carr

(507) 284-2511

carr.ryan@mayo.edu

More information

Publications

Publications are currently not available